Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06004440 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real World Registry for Use of the Ion Endoluminal System

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Aug 2029 to Aug 2027v6 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 3000 to confirmed 1301
    • Study completion date: Aug 2030 to Aug 2028
    • Site details revised at 16 of 16 sites
  2. Enrollment target: 2000 to 3000
    • Site details revised at 9 of 16 sites
    v5
  3. Enrollment target: 3000 to 2000
    • Primary completion date: Aug 2026 to Aug 2029
    • Study sites: 13 to 16
    • Study completion date: Aug 2027 to Aug 2030
    v4
  4. Study sites: 3 to 13v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 31, 2023 to Sep 21, 2023
    • Site details revised at 3 of 3 sites
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.
Trial Details
NCT Number NCT06004440
Lead Sponsor Intuitive Surgical
Conditions
(from sponsor)		 Lung Cancer, Multiple Pulmonary Nodules, Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms, Lung Diseases +1 more
Related terms Lung Diseases, Lung Neoplasms, Multiple Pulmonary Nodules, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms
Enrollment 1,301 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov